Evoke Pharma Inc. buy DomRuinart
Start price
18.11.20
/
50%
€32.66
Target price
18.11.21
€60.00
Performance (%)
-3.60%
End price
30.11.20
€31.49
Summary
This prediction ended on 30.11.20 with a price of €31.49. With a performance of -3.60%, the BUY prediction by DomRuinart finished with a loss. DomRuinart has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Evoke Pharma Inc. | -2.083% | -2.083% | -76.500% | -97.068% |
iShares Core DAX® | -0.870% | -1.700% | 10.560% | 13.129% |
iShares Nasdaq 100 | -5.561% | -3.604% | 34.335% | 39.856% |
iShares Nikkei 225® | -6.138% | -7.732% | 16.215% | 0.044% |
iShares S&P 500 | -3.141% | -2.011% | 24.534% | 39.859% |
According to DomRuinart what are the pros and cons of Evoke Pharma Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by DomRuinart for this prediction
In the thread Evoke Pharma Inc. diskutieren
Buy mit Kursziel 5,0
In the thread Trading Evoke Pharma Inc.
Buy beendet